Compare APLS & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APLS | SKE |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2015 | 2017 |
| Metric | APLS | SKE |
|---|---|---|
| Price | $20.64 | $37.59 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $31.79 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 875.7K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,003,782,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.57 | N/A |
| P/E Ratio | $103.98 | ★ N/A |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $8.53 |
| 52 Week High | $30.48 | $38.32 |
| Indicator | APLS | SKE |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 65.71 |
| Support Level | $18.95 | $14.67 |
| Resistance Level | $24.37 | N/A |
| Average True Range (ATR) | 0.97 | 1.67 |
| MACD | -0.14 | 0.27 |
| Stochastic Oscillator | 20.13 | 85.71 |
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.